Postnatal corticosteroids and neurodevelopmental outcomes in extremely low birthweight or extremely preterm infants: 15-year experience in Victoria, Australia

Conclusions
PCS use decreased in 2005 compared with earlier eras, and was accompanied by a rise in BPD, with no significant changes in mortality or neurological morbidity. (Source: Archives of Disease in Childhood – Fetal and Neonatal Edition)
Source: Blindness